David H. Humes
University of Michigan
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David H. Humes.
Circulation-cardiovascular Interventions | 2015
Judith Kooiman; Milan Seth; Brahmajee K. Nallamothu; Michael Heung; David H. Humes; Hitinder S. Gurm
Background—Acute kidney injury (AKI) post percutaneous coronary intervention (PCI) is associated with increased mortality but both death and AKI share common risk factors. Moreover, the effect of a high contrast dose, a known modifiable risk factor for AKI, on mortality is unknown. The aim of our study was to analyze the association between AKI and in-hospital mortality post PCI after adjustment for confounding by common risk factors. Methods and Results—This study was performed using a regional registry of all patients undergoing PCI in Michigan. Primary end points were AKI (serum creatinine increase >0.5 mg/dL) and all-cause in-hospital mortality. Propensity matching was performed, with each AKI patient matched to 4 controls. Attributable risk fraction and the exposed index number of AKI for mortality were calculated within the propensity-matched cohort. Between 2010 and 2013, 92 317 patients underwent PCI, of whom 2141 (2.3%) developed AKI. We matched 1371/2141 patients with AKI to 5484 controls. AKI was strongly associated with mortality (odds ratio=12.52, 95% confidence interval 9.29–16.86) in the propensity-matched cohort. The attributable risk fraction for mortality of AKI was 31.4% (95% confidence interval 26.8%–37.5%), and one death could be prevented for every 9 cases of AKI successfully avoided. The independent impact of a high contrast dose at time of PCI on in-hospital mortality risk was weak (adjusted odds ratio 1.19, 95% confidence interval 0.97–1.45). Conclusions—Nearly one-third of the in-hospital mortality post PCI is attributable to AKI. Preventing 9 cases of AKI could potentially prevent one death. These study findings stress the need for developing effective AKI preventive strategies beyond minimization of contrast dose.
Archive | 2000
David H. Humes; Andrew Levey; Karl Kjellstrand
We review the broad spectrum of research opportunities in aging, in general, and focus specifically on nephrology. I write here about general implementation strategies, and Dr. Levey will describe some of the methods the committee recommends to stimulate geriatric nephrology as a research area.
Archive | 2003
David H. Humes
Archive | 1994
Deborah A. Cieslinski; David H. Humes
Circulation | 2014
Judith Kooiman; Milan Seth; Brahmajee K. Nallamothu; Michael Heung; David H. Humes; Hitinder S. Gurm
Archive | 2013
David H. Humes; Deborah A. Buffington; Christopher J. Pino
Transplant International | 2011
Lauren Brasile; P. Glowacki; David H. Humes; Angela J. Westover; Deborah A. Buffington; Bart M. Stubenitsky
American Journal of Transplantation | 2011
L. Brasile; P. Glowacki; David H. Humes; A. Westover; D. Buffington; B. M. Stubenitsky
Cellular Transplantation#R##N#From Laboratory to Clinic | 2007
Khajohn Tiranathanagul; David H. Humes
Journal of The American College of Surgeons | 2006
Ian F. Lytle; Vikas Dhawan; Khajohn Tiranathanagul; Liandi Lou; Gregory H. Borschel; Evangelos Tziampazis; Deborah A. Buffington; Wen-Xiang Zhang; David H. Humes; David J. Brown